[Rethinking clinical research in surgical oncology. From comic opera to quality control].
Identifieur interne : 000003 ( France/Analysis ); précédent : 000002; suivant : 000004[Rethinking clinical research in surgical oncology. From comic opera to quality control].
Auteurs : Serge Evrard [France]Source :
- Bulletin du cancer ; 2016.
Abstract
The evidence base for the effectiveness of surgical interventions is relatively poor and data from large, randomized prospective studies are rare with often a poor quality. Many efforts have been made to increase the number of high quality randomized trials in surgery and theoretical proposals have been put forward to improve the situation, but practical implementation of these proposals is seriously lacking. The consequences of this policy are not trivial; with very few patients included in surgical oncology trials, this represents wasted opportunity for advances in cancer treatment. In this review, we cover the difficulties inherent to clinical research in surgical oncology, such as quality control, equipoise, accrual, and funding and promote alternative designs to the randomized controlled trial. Although the classic randomized controlled trial has a valid but limited place in surgical oncology, other prospective designs need to be promoted as a new deal. This new deal not only implicates surgeons but also journal editors, tender jury, as well as regulatory bodies to cover legal gaps currently surrounding surgical innovation.
DOI: 10.1016/j.bulcan.2015.10.006
PubMed: 26610367
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000029
- to stream PubMed, to step Curation: 000029
- to stream PubMed, to step Checkpoint: 000000
- to stream Ncbi, to step Merge: 000E50
- to stream Ncbi, to step Curation: 000E50
- to stream Ncbi, to step Checkpoint: 000E50
- to stream Main, to step Merge: 000003
- to stream Main, to step Curation: 000003
- to stream Main, to step Exploration: 000003
- to stream France, to step Extraction: 000003
Links to Exploration step
pubmed:26610367Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Rethinking clinical research in surgical oncology. From comic opera to quality control].</title><author><name sortKey="Evrard, Serge" sort="Evrard, Serge" uniqKey="Evrard S" first="Serge" last="Evrard">Serge Evrard</name><affiliation wicri:level="4"><nlm:affiliation>Université de Bordeaux, institut Bergonié, Inserm U1029, 229, cours de l'Argonne, 33076 Bordeaux, France. Electronic address: s.evrard@bordeaux.unicancer.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Bordeaux, institut Bergonié, Inserm U1029, 229, cours de l'Argonne, 33076 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName><orgName type="university">Université de Bordeaux</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26610367</idno><idno type="pmid">26610367</idno><idno type="doi">10.1016/j.bulcan.2015.10.006</idno><idno type="wicri:Area/PubMed/Corpus">000029</idno><idno type="wicri:Area/PubMed/Curation">000029</idno><idno type="wicri:Area/PubMed/Checkpoint">000000</idno><idno type="wicri:Area/Ncbi/Merge">000E50</idno><idno type="wicri:Area/Ncbi/Curation">000E50</idno><idno type="wicri:Area/Ncbi/Checkpoint">000E50</idno><idno type="wicri:Area/Main/Merge">000003</idno><idno type="wicri:Area/Main/Curation">000003</idno><idno type="wicri:Area/Main/Exploration">000003</idno><idno type="wicri:Area/France/Extraction">000003</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Rethinking clinical research in surgical oncology. From comic opera to quality control].</title><author><name sortKey="Evrard, Serge" sort="Evrard, Serge" uniqKey="Evrard S" first="Serge" last="Evrard">Serge Evrard</name><affiliation wicri:level="4"><nlm:affiliation>Université de Bordeaux, institut Bergonié, Inserm U1029, 229, cours de l'Argonne, 33076 Bordeaux, France. Electronic address: s.evrard@bordeaux.unicancer.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Bordeaux, institut Bergonié, Inserm U1029, 229, cours de l'Argonne, 33076 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName><orgName type="university">Université de Bordeaux</orgName></affiliation></author></analytic><series><title level="j">Bulletin du cancer</title><idno type="e-ISSN">1769-6917</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The evidence base for the effectiveness of surgical interventions is relatively poor and data from large, randomized prospective studies are rare with often a poor quality. Many efforts have been made to increase the number of high quality randomized trials in surgery and theoretical proposals have been put forward to improve the situation, but practical implementation of these proposals is seriously lacking. The consequences of this policy are not trivial; with very few patients included in surgical oncology trials, this represents wasted opportunity for advances in cancer treatment. In this review, we cover the difficulties inherent to clinical research in surgical oncology, such as quality control, equipoise, accrual, and funding and promote alternative designs to the randomized controlled trial. Although the classic randomized controlled trial has a valid but limited place in surgical oncology, other prospective designs need to be promoted as a new deal. This new deal not only implicates surgeons but also journal editors, tender jury, as well as regulatory bodies to cover legal gaps currently surrounding surgical innovation.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Aquitaine</li><li>Aquitaine-Limousin-Poitou-Charentes</li></region><settlement><li>Bordeaux</li></settlement><orgName><li>Université de Bordeaux</li></orgName></list><tree><country name="France"><region name="Aquitaine-Limousin-Poitou-Charentes"><name sortKey="Evrard, Serge" sort="Evrard, Serge" uniqKey="Evrard S" first="Serge" last="Evrard">Serge Evrard</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000003 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000003 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= OperaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= pubmed:26610367
|texte= [Rethinking clinical research in surgical oncology. From comic opera to quality control].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:26610367" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a OperaV1
| This area was generated with Dilib version V0.6.21. |  |